Health-Holland

The turnover* of the pharmaceutical sector in the Netherlands amounted to 33 billion euros in 2014, with a production value* of more than 29 billion euros. The turnover in the pharmaceutical sector in the Netherlands is predominantly from the distribution of medical articles (84%), and the manufacturing of pharmaceutical products (16%). Around 380 million euros is invested in R&D activities each year in the Netherlands: 250 million euros for internal R&D activities, and 130 million euros for external R&D costs. Turnover & investments * Turnover is the total volume of sales by a company (organisation, legal entity) over a given period. Production value is calculated by the value of production-related sales. Total turnover and production value in millions of euros Distribution of turnover Private investments in own R&D in millions of euros Turnover Production value Distribution of medical articles Manufacture of pharmaceutical products Own R&D Source: PwC, Economische Footprint Nederlandse Geneesmiddelensector, 2017 Source: PwC, Economische Footprint Nederlandse Geneesmiddelensector, 2017 Source: PwC, Economische Footprint Nederlandse Geneesmiddelensector, 2017 2010 2009 2011 2010 2012 2011 2013 2012 2014 2013 2014 40,000 35,000 30,000 25,000 20,000 15,000 10,000 5,000 0 500 450 400 350 300 250 150 100 50 0 37,592 33,937 35,782 30,512 32,135 28,723 33,169 29,352 33,075 26,789 415 382 442 262 244 256 84% 16% 29

RkJQdWJsaXNoZXIy NTYxMQ==